blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4049680

EP4049680 - NOVEL SUBSTITUTED CONDENSED RING COMPOUND [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  29.07.2022
Database last updated on 19.10.2024
FormerThe international publication has been made
Status updated on  03.05.2021
Most recent event   Tooltip05.07.2024Amendment by applicant 
Applicant(s)For all designated states
Sumitomo Pharma Co., Ltd.
6-8, Doshomachi 2-chome
Chuo-ku
Osaka-shi
Osaka 541-0045 / JP
[2022/35]
Inventor(s)01 / KOIKE, Sachiko
c/o Sumitomo Pharma Co., Ltd., 1-98, Kasugadenaka
3-chome, Konohana-ku
Osaka-shi, Osaka 554-0022 / JP
02 / IKUMA, Yohei
c/o Sumitomo Pharma Co., Ltd., 1-98, Kasugadenaka
3-chome, Konohana-ku
Osaka-shi, Osaka 554-0022 / JP
03 / FUKAYA, Takayuki
c/o Sumitomo Pharma Co., Ltd., 1-98, Kasugadenaka
3-chome, Konohana-ku
Osaka-shi, Osaka 554-0022 / JP
04 / UESUGI, Shunichiro
c/o Sumitomo Pharma Co., Ltd., 1-98, Kasugadenaka
3-chome, Konohana-ku
Osaka-shi, Osaka 554-0022 / JP
 [2022/35]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstraße 3
81675 München / DE
[2022/35]
Application number, filing date20880018.523.10.2020
[2022/35]
WO2020JP39897
Priority number, dateJP2019019475325.10.2019         Original published format: JP 2019194753
[2022/35]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021079984
Date:29.04.2021
Language:JA
[2021/17]
Type: A1 Application with search report 
No.:EP4049680
Date:31.08.2022
Language:EN
[2022/35]
Search report(s)International search report - published on:JP29.04.2021
(Supplementary) European search report - dispatched on:EP13.12.2023
ClassificationIPC:A61K45/00, A61P1/02, A61P1/16, A61P7/00, A61P9/00, A61P11/00, A61P11/02, A61P11/04, A61P13/02, A61P15/00, A61P19/02, A61P27/02, A61P27/16, A61P29/00, A61P31/04, A61P31/10, A61P31/12, A61P37/08, A61P43/00, C07F5/02, A61P17/00
[2022/35]
CPC:
A61P1/02 (EP); C07F5/025 (EP,KR,US); A61K31/352 (EP);
A61K31/397 (EP); A61K31/69 (KR); A61K45/06 (EP);
A61P1/16 (EP); A61P11/00 (EP); A61P11/02 (EP);
A61P11/04 (EP); A61P13/02 (EP); A61P15/00 (EP);
A61P17/00 (EP); A61P17/02 (EP); A61P19/02 (EP);
A61P27/02 (EP); A61P27/16 (EP); A61P29/00 (EP);
A61P31/04 (EP,KR); A61P31/10 (EP); A61P31/12 (EP);
A61P37/08 (EP); A61P43/00 (EP); A61P7/00 (EP);
A61P9/00 (EP); C07F5/04 (EP) (-)
C-Set:
A61K31/352, A61K2300/00 (EP);
A61K31/397, A61K2300/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/35]
TitleGerman:NEUARTIGE SUBSTITUIERTE KONDENSIERTE RINGVERBINDUNG[2022/35]
English:NOVEL SUBSTITUTED CONDENSED RING COMPOUND[2022/35]
French:NOUVEAU COMPOSÉ CYCLIQUE CONDENSÉ SUBSTITUÉ[2022/35]
Entry into regional phase23.05.2022Translation filed 
23.05.2022National basic fee paid 
23.05.2022Search fee paid 
23.05.2022Designation fee(s) paid 
23.05.2022Examination fee paid 
Examination procedure23.05.2022Examination requested  [2022/35]
04.07.2024Amendment by applicant (claims and/or description)
04.07.2024Date on which the examining division has become responsible
Fees paidRenewal fee
24.10.2022Renewal fee patent year 03
23.10.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO2018005662  (REMPEX PHARMACEUTICALS INC [US]) [Y] 1-26* boronic acid tricyclic heterocycles and their use in pharmaceutical compositions (see claims 77-81) and for treatment of bacterial infections (see claims 84-88) through beta-lactamase inhibition (see claims 80 and 87). *;
 [YP]WO2019208797  (SUMITOMO DAINIPPON PHARMA CO LTD [JP], et al) [YP] 1-26 * compounds of table 3, pages 561-564; use of compounds as beta-lactamase inhibitors (see claim 72), in pharmaceutical compositions (see claims 84-85) and for treatment of bacterial infections (see claims 86-89) *
International search[A]JP2014524446  (GLAXOSMITHKLINE LLC) [A] 1-143* claims 1-13 *;
 [A]JP2014527529  (GLAXO GROUP LIMITED) [A] 1-143 * claims 1-22 *;
 [A]WO2016149393  (REMPEX PHARMACEUTICALS INC [US]) [A] 1-143 * claims 1-154 *;
 [A]JP2017517508  (REMPEX PHARMACEUTICALS, INC.) [A] 1-143 * claims 1-118 *;
 [A]WO2019009369  (SUMITOMO DAINIPPON PHARMA CO LTD [JP], et al) [A] 1-143 * claims 1-121 *
by applicant   - BUYNAK. JD, Expert Opinion on Therapeutic Patents, (20130000), vol. 23, no. 11, pages 1469 - 1481
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.